Cerebrotoxicity of antihypertensive therapy in the UK Biobank Cohort Study

Franz H Messerli^{1

2

3}, Chirag Bavishi⁴, Adrian W Messerli⁵, George C M Siontis¹

Affiliations

¹ Department of Cardiology, Bern University Hospital, University of Bern, Switzerland.
² Jagiellonian University, Krakow, Poland.
³ Division of Cardiology, Mount Sinai Health Medical Center, Icahn School of Medicine, New York, NU, USA.
⁴ University of Missouri at Columbia, Columbia, MO, USA.
⁵ Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY, USA.

Comment

Franz H Messerli et al. Eur Heart J. 2021.

. 2021 Nov 1;42(41):4282.

doi: 10.1093/eurheartj/ehab567.

Franz H Messerli^{1

2

3}, Chirag Bavishi⁴, Adrian W Messerli⁵, George C M Siontis¹

¹ Department of Cardiology, Bern University Hospital, University of Bern, Switzerland.
² Jagiellonian University, Krakow, Poland.
³ Division of Cardiology, Mount Sinai Health Medical Center, Icahn School of Medicine, New York, NU, USA.
⁴ University of Missouri at Columbia, Columbia, MO, USA.
⁵ Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY, USA.

No abstract available

Comment on

Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study.
Wartolowska KA, Webb AJS. Wartolowska KA, et al. Eur Heart J. 2021 Feb 14;42(7):750-757. doi: 10.1093/eurheartj/ehaa756. Eur Heart J. 2021. PMID: 33238300 Free PMC article.
On cerebrotoxicity of antihypertensive therapy and risk factor cosmetics.
Messerli FH, Bavishi C, Messerli AW, Siontis GCM. Messerli FH, et al. Eur Heart J. 2021 Feb 14;42(7):758-760. doi: 10.1093/eurheartj/ehaa971. Eur Heart J. 2021. PMID: 33369623 No abstract available.
Big cohort studies offer insights into preventable risk factors.
Wartolowska KA, Webb AJS. Wartolowska KA, et al. Eur Heart J. 2021 Nov 1;42(41):4280-4281. doi: 10.1093/eurheartj/ehab566. Eur Heart J. 2021. PMID: 34480539 Free PMC article. No abstract available.